The final rule changes to Patent Trial and Appeal Board proceedings will likely help to reduce the rate of institution of trials, especially allowing patent owners to include relevant testimonial evidence in preliminary responses. There was one surprise, however, with the USPTO dropping a proposed pilot programme
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
CMS IndusLaw co-founder Suneeth Katarki says he plans to hire a patent team in India and argues that IP should play a major role within full-service firms
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application